DE3751811T2 - LH-RH-Analoga enthaltende Formulierungen - Google Patents

LH-RH-Analoga enthaltende Formulierungen

Info

Publication number
DE3751811T2
DE3751811T2 DE3751811T DE3751811T DE3751811T2 DE 3751811 T2 DE3751811 T2 DE 3751811T2 DE 3751811 T DE3751811 T DE 3751811T DE 3751811 T DE3751811 T DE 3751811T DE 3751811 T2 DE3751811 T2 DE 3751811T2
Authority
DE
Germany
Prior art keywords
analogs
formulations containing
relates
aerosol formulations
suspension aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3751811T
Other languages
English (en)
Other versions
DE3751811D1 (de
Inventor
Akwete L Adjei
James W Kesterson
Edwin S Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/934,874 external-priority patent/US4851211A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE3751811D1 publication Critical patent/DE3751811D1/de
Application granted granted Critical
Publication of DE3751811T2 publication Critical patent/DE3751811T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
DE3751811T 1986-11-25 1987-11-23 LH-RH-Analoga enthaltende Formulierungen Expired - Fee Related DE3751811T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/934,874 US4851211A (en) 1986-11-25 1986-11-25 LHRH analog formulations
US07/114,359 US4897256A (en) 1986-11-25 1987-11-04 LHRH analog formulations

Publications (2)

Publication Number Publication Date
DE3751811D1 DE3751811D1 (de) 1996-06-20
DE3751811T2 true DE3751811T2 (de) 1996-11-28

Family

ID=26812097

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3751811T Expired - Fee Related DE3751811T2 (de) 1986-11-25 1987-11-23 LH-RH-Analoga enthaltende Formulierungen
DE87117226T Expired - Fee Related DE3785570T2 (de) 1986-11-25 1987-11-23 Zusammensetzungen enthaltend LHRH-Analoga.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE87117226T Expired - Fee Related DE3785570T2 (de) 1986-11-25 1987-11-23 Zusammensetzungen enthaltend LHRH-Analoga.

Country Status (7)

Country Link
US (1) US4897256A (de)
EP (2) EP0510731B1 (de)
JP (1) JP2533586B2 (de)
AT (1) ATE137963T1 (de)
CA (1) CA1300009C (de)
DE (2) DE3751811T2 (de)
ES (2) ES2089301T3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
WO1995003034A1 (en) * 1993-07-19 1995-02-02 Amgen Inc. Stabilization of aerosolized proteins
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US7572252B1 (en) * 1995-06-07 2009-08-11 Alza Corporation Electrotransport agent delivery method and apparatus
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
SK284490B6 (sk) * 1996-07-03 2005-05-05 Alza Corporation Stabilná nevodná formulácia a spôsob jej prípravy
US5981489A (en) * 1996-07-18 1999-11-09 Alza Corporation Non-aqueous protic peptide formulations
PT954282E (pt) * 1997-01-16 2005-06-30 Massachusetts Inst Technology Preparacao de particulas para inalacao
EP1498115A1 (de) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Zubereitung von partikelhaltigen Arzneimitteln zur Inhalation
US6099851A (en) * 1998-06-02 2000-08-08 Weisman; Kenneth M. Therapeutic uses of leuprolide acetate
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
DE10043509A1 (de) * 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
EP1345629A2 (de) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Inhalationspartikel mit verzögerter freigabe
US20030035774A1 (en) * 2001-07-18 2003-02-20 Adjei Akwete L. Salt/ion pair medicinal aerosol formulation
WO2005011658A2 (en) 2003-02-27 2005-02-10 Wisconsin Alumni Research Foundation Chroman-derivated anti-androgens for treatment of androgen-mediated disorders
US7279181B2 (en) * 2003-06-03 2007-10-09 Ferro Corporation Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
WO2005077339A1 (en) * 2004-02-10 2005-08-25 E.I. Dupont De Nemours And Company Process for preparing stable sol of pharmaceutical ingredients and hydrofluorocarbon comprising milling the said sol, then transfert it into a canister
HUE026152T2 (en) * 2004-04-23 2016-05-30 Philip Morris Products Sa Aerosol Generator and Method for Aerosol Production

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3898329A (en) * 1971-09-17 1975-08-05 Sami I Said Vasoactive intestinal peptide, composition and method
DE2254061A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Lh-releasing hormon zur nasalen applikation
GB1454105A (en) * 1972-11-04 1976-10-27 Hoechst Ag Preparation containing luteinizing hormone-releasing factor
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4438029A (en) * 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
JPH0625068B2 (ja) * 1982-12-10 1994-04-06 シンテツクス（ユ−・エス・エ−・）インコ−ポレイテイド 鼻腔内投与用組成物及びその製造方法
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation

Also Published As

Publication number Publication date
DE3785570T2 (de) 1993-11-18
JP2533586B2 (ja) 1996-09-11
EP0275404A1 (de) 1988-07-27
JPS63211237A (ja) 1988-09-02
ES2040727T3 (es) 1993-11-01
EP0510731B1 (de) 1996-05-15
CA1300009C (en) 1992-05-05
DE3751811D1 (de) 1996-06-20
EP0275404B1 (de) 1993-04-21
ATE137963T1 (de) 1996-06-15
ES2089301T3 (es) 1996-10-01
US4897256A (en) 1990-01-30
EP0510731A1 (de) 1992-10-28
DE3785570D1 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
DE3887513T2 (de) Chemische formulierungen.
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
NO872201D0 (no) Stabilisering av multivitamin/sporelement-formuleringer.
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
DE3779053D1 (de)
DK631688A (da) 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
TR23424A (tr) 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri
IT1203945B (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine
ZW1187A1 (en) Insecticidal trifluromethyl alkane derivatives
IT8621342A0 (it) Analoghi di ammide-tioammide prostaglandina 7 ossabicicloeptano sostituiti.
IT1223405B (it) Procedimento per la metilazione di composti triazinici contenenti gruppi 2,2,6,6 tetrametilpiperidinici
BR8703717A (pt) Formulacao pesticida do tipo suspensao estavel
DE3874594D1 (de) Gaenzlich waesserige formulierungen von organophosphorpestiziden.
IL90220A0 (en) Anticoagulant peptide alcohols
IT1208493B (it) Analoghi di ossaprostaglandina 7-ossabicicloeptano sostituiti.
IT8522963A0 (it) Composizione disinfettante per via aerea.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
ATE88341T1 (de) Zusammensetzungen enthaltend lhrh-analoga.
FI884483A0 (fi) 1 (2h)-ftalatsinoler som cellskyddande medel.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
FI863546A0 (fi) Foerfarande foer framstaellning av bis-( -(3,5-di-butyl-4-hydroxibentsyl)-metyl-karboxietyl)sulfid.
SE8705030D0 (sv) Substans p-analoger
DE3779302D1 (de) Ubidecarenon enthaltende kosmetische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee